Rapidly growing mycobacteria (RGM) are respiratory pathogens in patients with cystic fibrosis (CF), but detection generally requires specialized cultures for acid-fast bacilli (AFB; AFB cultures). We determined that RGM could be recovered from routine cultures of samples from patients with CF by extending incubation of the Burkholderia cepacia selective agar (BCSA) from 5 to 14 days. To explore the impact of this modification, we compared results from routine and AFB cultures of samples from CF patients for 2 years before (4,212 samples by routine culture, 1,810 samples by AFB culture, 670 patients) and 2 years after (4,720 samples by routine culture, 2,179 samples by AFB culture, 695 patients) the change. Clinical relevance was assessed with samples from a subgroup of 340 patients followed regularly throughout both periods. Extending incubation of BCSA enhanced RGM recovery from routine cultures (0.7% before, 2.8% after; P < 0.001); recovery from AFB cultures was unchanged (5.5% before, 5.7% after). Estimates of RGM detection sensitivity by culture or patient-based methods ranged from ϳ65 to 75% for routine cultures (nonsignificantly lower than the ϳ80 to 85% for AFB cultures) and were adversely affected by coculture with mold or nonpseudomonal, nonfermenting Gram-negative rods. In the after period, 16 CF patients met the criteria for RGM infection by routine culture, including 4 who did not meet the criteria for RGM infection by AFB culture. We conclude that a simple methodological change enhanced recovery of RGM from routine cultures. The modified culture method could be utilized to improve screening for RGM in CF patients or as a simpler method to follow patients with known RGM infection. However, this method should be used cautiously in patients with certain coinfections.Rapidly growing mycobacteria (RGM) represent a subgroup of environmental mycobacteria that includes the commonly recognized pathogen Mycobacterium abscessus as well as other species, such as M. fortuitum and M. chelonae (1). Accumulating evidence suggests that RGM are significant respiratory pathogens within patients with chronic lung diseases such as cystic fibrosis (CF) (2,8). A large prospective study showed that RGM respiratory infection was relatively common in CF patients (prevalence, 2.3%) (12), and CF patients with chronic RGM infection have been shown to have greater declines in lung function over time (3).Although these data suggest that RGM are significant pathogens in patients with CF, detection of RGM respiratory infection poses considerable challenges. While RGM are capable of growth on many standard culture media, they grow relatively slowly (they are rapidly growing only relative to the rate of growth of other mycobacteria) and are typically overgrown by other common CF pathogens, such as Pseudomonas aeruginosa, on nonselective agar. As a result, detection of RGM in respiratory secretions from patients with CF is generally performed using culture for acid-fast bacilli (AFB; AFB culture) by techniques that involve a decontami...